Cancer Pharmacogenomics
Cancer pharmacogenomics is the study of how individuals’ genetic make-up can influence their response to cancer treatments. Through pharmacogenomics, cancer treatments can be personalized to work more effectively, ensuring that the right drug is given to the right patient at the right dose. By understanding an individual’s genetic profile, pharmacogenomics provides a better understanding of how cancer will respond to specific treatments and helps clinicians and researchers develop new therapies. By utilizing this personalization of cancer treatment, pharmacogenomics could greatly improve the outcome of cancer therapy, increasing the effectiveness of treatments and improving the prognosis for many cancer patients.
← Journal of Cancer Genetics And Biomarkers